This page lists the names of Steering Committee, the Standards Committee, and the Delphi Panel.

Steering Committee

     The objective of the Steering Committee is to help the Population Health Impact (PHI) Institute's Standards Committee (SC) lead an effort to develop Transparency Standards and Attribution Standards to be used for the credible and impartial judgment of the validity of the claims made by population health improvement programs.  These "quality evaluation processes sm " (QEP sm ) based-standards will be designed to credibly test the hypothesized linkage -- the causal pathway -- between a defined population health intervention and one or more outcome metrics. Such defined population health improvement interventions include wellness, health promotion, care management, case management, disease management, payment-for-performance, consumer directed health plans, etc.; while outcome metrics include measures related to health, economics, functionality, satisfaction, etc.

     The Transparency Standards will be based on the Population Health Impact Institute's Ethical Principles (objectivity, disclosure of interests, disclosure of impact methodologies) and the Attribution Standards will stem from the Institute's Five Evaluation Principles (data quality, equivalence, statistical quality, causality, and generalizability).

   The PHI Institute's Steering Committee of the Standards Commission (members listed below) believes that health care industry in general, and purchasers of defined population health improvement services in particular, are in need of trustworthy and fair standards.  They also believe that health care professionals desire that such standards be developed by an impartial, non-partisan organization with founding goals that include fairness, independence, objectivity, i.e., seeking the truth; and avoiding the promotion of one particular industry type, or the services of any specific company or companies, or even a special management philosophy or theory toward population healthimprovement.

    Thus, the standards themselves will be vetted by a balanced group of buyers (users) and sellers and independent scientists prior to official use.  These individuals will be made up of anyone supporting the mission of the PHI Institute, including those who now sit (or will sit in the future) on PHI Institute's Delphi Panel (made up of scientists) and its Grant Advisory Panel (made up of scientists, sellers, and buyers).  The ultimate standards will be transparent and "open-source" to achieve their ultimate goal: To enable the marketplace to compare and contrast program claims from different interventions in a standardized and objective manner. To put it succinctly, the overall effort of the SC is to develop scientifically credible and trustworthy Transparent & Attribution Standards that are "generally accepted." Eventually these standards may be used to help score the degree to which organizations and programs adhere to them. 

     The members of the core Steering Committee are listed below.  In the next few months, these individuals will help the PHI Institute structure the official mission, goals, and membership of the full Standards Commission.

CHAIR: Joel V. Brill, MD AGAF FASGE FACG CHCQM. Chief Medical Officer, Predictive Health, LLC; Chair, CME Committee, American Board of Quality Assurance and Utilization Review Physicians, Inc (ABQAURP).

Garry Carneal, JD, MA.  President & CEO, Schooner Health Care LLC; Board member, ABQAURP.  Chair, PHII Accreditation Standards Committee.

Dee Edington, PhD. Health Management Research Center , University of Michigan

Jeffrey Guterman, MD. Senior Medical Director, LA County Department of Health; Professor of Medicine, UCLA.

Jeffrey Gruen, MD, MBA. Chief Medical Officer, Revolution Health, Washington , DC .

Brian Klepper, PhD. CEO, Center for Practical Health Care Reform

Vince Kuraitis, Esq.   Principal, Better Health Technologies.

Cheri Lattimer, RN, BSN.   Executive Director, Case Management Society of America .

Steven Locke, MD. Harvard Medical School , Health Sciences and Technology, MIT; Principal, Veritas Health Solutions.

Michael L. Millenson. Mervin Shalowitz Visiting Scholar at Northwestern University 's Kellogg School of Medicine; Independent health care consultant.

Gary Montrose. President, Ashby-Montrose & Co. Co-founder Population Health Impact Institute.

Patricia Salber, MD, MBA.  Chief Medical Officer, Universal American Co.,  Former Director of the Center for Healthcare Improvement, Blue Shield of California. 

Sean Sullivan, JD. President & CEO, Institute for Health and Productivity Management (IHPM)

Thomas Wilson, PhD, DrPH. Founder & Board Chair, Population Health Impact Institute, Principal & Epidemiologist, Trajectory Healthcare, LLC

1-9-06, 1-24-06, 5-5-06, 8-16-07

Standards Committee

CHAIR: Garry Carneal, JD, MA. President & CEO, Schooner Healthcare LLC, and former President & CEO, URAC.

Joel V. Brill, MD. Chief Medical Officer, Predictive Health, LLC and Assistant Clinical Professor of Medicine, University of Arizona College of Medicine.

David Brumley, MD, MBA. Medical Director Health Management, Medical Innovation and Leadership; Blue Cross Blue Shield of Massachusetts.

Vicki Darlington, MPH. Corporate Wellness, Entergy Services, Inc.

Carolyn K. Hamm, PhD. Chief Decision Support Center , Medical Management, Walter Reed Army Medical Center

James Kepner, PhD. Vice President, Statistics and Evaluation Center ; American Cancer Society; Marc Leib, MD JD, Chief Medical Officer, Arizona Health Care Cost Containment System.

Martin MacDowell, DrPH, MBA. Research Associate Professor, University of Illinois at Rockford.

Jaan Sidorov, MD, MHSA, FACP. Consultant, and former Medical Director, Geisinger Health Plan.

Mary Madison, MPA. Madison Consulting Group, formerly Managing Director, Health Services Research and Strategic Initiatives, Blue Cross and Blue Shield Association.

Minalkumar Patel, MD, MPH. CEO, Care Management International Inc.

Susan Riley. Independent Consultant, and former CEO, AirLogix.

Sunil K Sinha MD, MBA, FACHE. Senior Medical Officer, Centers for Medicare and Medicaid Services.

Grace-Marie Turner. Founder, President and Trustee, Galen Institute, Inc.

Joshua Slen. Director, Vermont Medicaid.

Mary Wieg, RN, MBA. Nurse Consultant II, CalPERS Office of Health Policy Research.

Delphi Panel

The following individuals--experts in quantitative analysis and/or clinical care--have agreed to participate in structured review process designed to assess the validity of methods used to measure the value of defined population health management programs.

The panel, chaired by Dr. Patricia Salber, works within the framework established by the five evaluation principles of the PHI Institute. 

Examples of projects completed or are currently in-process include: An examination 18 peer-reviewed articles related to worksite health promotion and disease management that was published in fall 2006 issue of Journal of Health and Productivity. Another is now assessing 25 peer-reviewed articles, scientifically chosen, on disease management (DM) in health plans. The project, entitled "Quality of Methods & Strength of Evidence for Disease Management Evaluation," is funded by the Health Industry Forum at Brandeis University.  Other projects will score the transparency and validity of non-scientifically selected documents on DM, case management, Payment for Performance, and other population health programs.   It is not a requirement that all documents be peer-reviewed.

Disclosure: No financial relationship exists between the PHI Institute and any member of this panel or companies with which they are associated except as disclosed here: Members of the Delphi panel may receive honorariums from the PHI Institute for the services provided.  If a panel member discloses a financial interest with one of the parties in a study undergoing a review, he or she will not participate in the Delphi panel's scoring for that particular session.  Opinions expressed by these individuals on evaluation topics are not official positions of the PHI Institute. 11/17/05

CHAIR: Patricia Salber, MD, MBA.  Chief Medical Officer, Universal American Co.,  Former Director of the Center for Healthcare Improvement, Blue Shield of California. 

Joseph P. Courtney, PhD. Epidemiologist, Berkeley, California.  Directs the Research and Evaluation section for a large government agency. Prior positions include Senior Epidemiologist, Public Health Foundation Enterprises; and Chief Epidemiologist, Los Angeles County Department of Health Services, STD program.

Ian Duncan, FSA, FIA, FCIA, MAAA.  President, Solucia Inc.  Hartford, CT.  Co-author "Actuarial Issues in Care Management Interventions" (7 paper series). Society of Actuaries, 2004-5.

Karen Fitzner, PhD.  Principal, Fiscal Health, LLC.  Former Director of Research and Program Planning, Disease Management Association of America.

Clarence E. Grim, MD, FACP, FACC, FAHS. Clinical Professor of Medicine and Epidemiology, University of Wisconsin-Milwaukee.

Jeffery Guterman, MD. Senior Medical Director, LA County Department of Health, and Professor of Medicine, David Geffen School of Medicine, UCLA.

Catherine K. Hamm, PhD. Chief Decision Support Center, Medical Management, Walter Reed Army Medical Center, Washington DC.

Paul Jenkins, PhD. Director of Statistics and Computing, Mary Imogene Bassett Research Institute, Cooperstown, NY.  Adjunct Instructor of Biometry and Statistics, SUNY-Albany.

Ariel Linden, MS, DrPH. President, Linden Consulting.  Assistant Clinical Professor, School of Medicine & Adjunct Professor, School of Nursing, Oregon Health and Science University, Portland, OR.

Martin MacDowell, DrPH, Associate Professor, University of Illinois, Rockford, IL. Co-author, Framework for Assessing Causality in Disease Management (DMAA).

****************************************************************************

Panelists with real or potential conflict of interest will recuse themselves from participating on programs or from reviewing specific documents.

****************************************************************************